278 related articles for article (PubMed ID: 2142624)
1. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
[TBL] [Abstract][Full Text] [Related]
2. Plasma viremia in human immunodeficiency virus infection.
Coombs RW; Collier AC; Allain JP; Nikora B; Leuther M; Gjerset GF; Corey L
N Engl J Med; 1989 Dec; 321(24):1626-31. PubMed ID: 2511447
[TBL] [Abstract][Full Text] [Related]
3. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
4. Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection.
Forster SM; Osborne LM; Cheingsong-Popov R; Kenny C; Burnell R; Jeffries DJ; Pinching AJ; Harris JR; Weber JN
AIDS; 1987 Dec; 1(4):235-40. PubMed ID: 3126771
[TBL] [Abstract][Full Text] [Related]
5. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
[TBL] [Abstract][Full Text] [Related]
7. [Subjects infected with human immunodeficiency virus: serological markers of prognostic value].
Hurtado C; Velasco M; Sepúlveda C
Rev Med Chil; 1989 Mar; 117(3):251-7. PubMed ID: 2488516
[TBL] [Abstract][Full Text] [Related]
8. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J
AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infection.
Croxson TS; Mathur-Wagh U; Handwerger S; Siroty WE; Kaminisky D; Reagan KJ; Yancovitz SR; Mildvan D
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):455-63. PubMed ID: 2111160
[TBL] [Abstract][Full Text] [Related]
10. Passive immunization in ARC and AIDS.
Karpas A; Gray J; Byron N; Gilgen D; Bally V; Oates JK; Gazzard B
Biotherapy; 1990; 2(2):159-72. PubMed ID: 2144762
[No Abstract] [Full Text] [Related]
11. [Diagnostico-prognostic significance of the analysis of anti-HIV antibodies and viral antigens in acquired immunodeficiency syndrome. Presentation of 2 paradigmatic cases].
Venturini L; Serpelloni G; Parolin A; Mezzelani P
G Clin Med; 1989 May; 70(5):353-6. PubMed ID: 2753265
[TBL] [Abstract][Full Text] [Related]
12. Detection of serum HIV-Ag related to the major core protein (p24) in persons at risk for AIDS.
Borghi V; De Rienzo B; Pietrosemoli P; Pecorari M; Mongiardo N; Pellegrino F; Zanchetta GP; Lami G; Squadrini F
Microbiologica; 1989 Jan; 12(1):81-3. PubMed ID: 2497304
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
Zagury JF; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo RC; Zagury D
J Hum Virol; 1998; 1(4):282-92. PubMed ID: 10195253
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
[TBL] [Abstract][Full Text] [Related]
15. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group.
Busch MP; Taylor PE; Lenes BA; Kleinman SH; Stuart M; Stevens CE; Tomasulo PA; Allain JP; Hollingsworth CG; Mosley JW
N Engl J Med; 1990 Nov; 323(19):1308-12. PubMed ID: 2120588
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
Schulte C; Meurer M; Fröschl M
Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
[TBL] [Abstract][Full Text] [Related]
17. HIV-p24-antigen-bearing macrophages are only present in brains of HIV-seropositive patients with AIDS-encephalopathy.
Schindelmeiser J; Gullotta F
Clin Neuropathol; 1991; 10(3):109-11. PubMed ID: 1907231
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
[TBL] [Abstract][Full Text] [Related]
19. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
Clark SJ; Saag MS; Decker WD; Campbell-Hill S; Roberson JL; Veldkamp PJ; Kappes JC; Hahn BH; Shaw GM
N Engl J Med; 1991 Apr; 324(14):954-60. PubMed ID: 1900576
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
